Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.

• Status: Completed
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to collect data on tolerance and effects of early treatment with oxytocin in children with Prader Willi Syndrome aged from 3 to 4 years and to compare these infants with not treated age-matched infants with Prader Willi Syndrome.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Toulouse
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• Infants with Prader Willi Syndrome (genetic diagnosis confirmed)

• For treated group : infant included in the ancient study

• For not treated group: infant never treated with oxytocin

Exclusion Criteria:

• Subject involved in another search including an exclusion period still in progress at the time of inclusion.

• Impossibility to give parents or legal guardian informed information

• No coverage by a Social Security scheme

• Refusal of parents or legal representative to sign consent.

If a patient has a contraindication to Magnetic resonance imaging, it may be included in the study but Magnetic resonance imaging will not be performed.